Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are higher doses of rifaximin more effective for the treatment of small-intestinal bacterial overgrowth?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 22–23 (2006)Cite this article

boxed-textLauritano EC et al. (2005) Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol 22: 31–35

The culture of small-intestinal aspirates or unwashed mucosal biopsies is the only reliable method for establishing a diagnosis of small-intestinal bacterial overgrowth

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kalser MH et al. (1966) Normal viral and bacterial flora of the human small and large intestine. N Engl J Med 274: 500–505

    Article  CAS  Google Scholar 

  2. Riordan SM (1996) A critical appraisal of diagnostic tests for small intestinal bacterial overgrowth. Gastroenterol Internat 9: 110–119

    Google Scholar 

  3. Riordan SM et al. (1995) Bacteriologic analysis of mucosal biopsy specimens for detecting small-intestinal bacterial overgrowth. Scand J Gastroenterol 30: 681–685

    Article  CAS  Google Scholar 

  4. King CE and Toskes PP (1986) Comparison of the 1-gram 14C-xylose, 10-gram lactulose-H2 and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 91: 1447–1451

    Article  CAS  Google Scholar 

  5. Corazza GR et al. (1990) The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 98: 302–309

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Gastroenterology and the Acting Chairman Department of Gastroenterology at the University Hospital, Basel, Switzerland

    Christoph Beglinger

  2. Assistant Professor of Gastroenterology, in the Department of Gastroenterology at the University Hospital, Basel, Switzerland

    Lukas Degen

Authors
  1. Christoph Beglinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lukas Degen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Beglinger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beglinger, C., Degen, L. Are higher doses of rifaximin more effective for the treatment of small-intestinal bacterial overgrowth?. Nat Rev Gastroenterol Hepatol 3, 22–23 (2006). https://doi.org/10.1038/ncpgasthep0371

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0371

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing